Developer docs
API playgroundTry for free, no card

Search company profiles

Paragon Healthcare

Full company profile

uuid0007o6o

Namestring
Paragon Healthcare
Legal namestring
Paragon Healthcare, Inc.
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Paragon Healthcare, founded in 2002 and headquartered in Dallas, Texas, is a specialty infusion services provider that delivers injectable and infusible drug therapies through three integrated channels: in-home infusion, a network of company-operated outpatient infusion centers, and specialty pharmacy dispensing. The company treats more than 300 chronic and acute conditions across neurology, rheumatology, gastroenterology, immunology, dermatology, hematology, and hepatology, with particular depth in hemophilia and other bleeding disorders, IVIG/SCIG therapy for primary immunodeficiency and autoimmune disease, and rare disease care. As of 2024, Paragon served over 35,000 patients annually, employed more than 1,000 staff, and operated 40+ infusion center and pharmacy locations across 10+ U.S. states, with a publicly stated plan to add 50+ additional locations over the following five years.

The underlying technology platform combines electronic health information systems, telehealth-enabled patient education for self-administration of infusion pumps and drug therapy, and a national overnight shipping logistics operation that delivers ready-to-use medications and supplies directly to patients. The company operates four core product lines — Paragon Infusion Centers, Paragon Home Infusion, Paragon Hemophilia, and Paragon Specialty Pharmacy — plus an in-office infusion suite offering for physician practices. Paragon holds dual URAC and ACHC accreditations and is HIPAA-compliant, with URAC specialty pharmacy accreditation valid through December 1, 2027. The organization maintains 11 disclosed wholly-owned subsidiaries supporting capabilities such as hemophilia solutions, infusion care, nutrition care, reimbursement, and regional pharmacy operations.

Paragon generates revenue through insurance billing for specialty medications, infusion administration, and care-coordination services (including prior authorizations and benefits verification), supplemented by patient financial assistance programs connected through NeedyMeds and manufacturer programs. Its go-to-market is physician-led referral combined with direct patient outreach, supported by a clinical team of pharmacists, registered nurses, and patient care representatives. Founder-led for two decades, the company received a private-equity investment from Peak Rock Capital in 2020, transitioned to new CEO Anthony Mollica in 2021, and was acquired by Elevance Health in 2024, where it now operates as part of the Carelon health services platform.

Short descriptiontext

Paragon Healthcare is a Dallas-based specialty infusion services provider delivering injectable and infusible drug therapies across 40+ U.S. locations through home infusion, outpatient infusion centers, and specialty pharmacy, serving 35,000+ patients annually with chronic and rare conditions including hemophilia and IVIG-therapy indications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersDallas, United States
HQ citystring
Dallas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices49 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty infusion therapy, home infusion services, specialty pharmacy dispensing, hemophilia treatment management, IVIG therapy services
Industry5 codes
1Infusion & Home Infusion Pharmacy Services
CodeHLAFALAGPrimaryYes
2Home Infusion Therapy Providers
CodeHLAFAEAEPrimaryNo
3Infusion Therapy Centers (Outpatient)
CodeHLAFABAFPrimaryNo
4Specialty Injectable & Infusion Therapies (Cross-therapeutic)
CodeHLAIACAOPrimaryNo
5In-Home Infusion Pharmacy Support & Coordination
CodeHSABALAHPrimaryNo
NAICS code3 codes
  • All Other Outpatient Care Centers621498
  • Other Ambulatory Health Care Services6219
  • Ambulatory Health Care Services621
SIC code3 codes
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Misc Health & Allied Services, Nec8090
  • Services-Health Services8000
Product category
Specialty Infusion Therapy Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Specialty Pharmacy and Infusion Services
TypeSubscription Recurring
Description

Revenue is generated through the provision of specialty injectable and infusible drug therapies, administered either in the patient's home, at one of Paragon's infusion centers, or through specialty pharmacy dispensing. The company handles billing for medications, infusion services, and related care coordination services including prior authorizations and reimbursement management. As of 2018, the company reported approximately $275 million in annual revenue.

paragonhealthcare.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Patient Financial Assistance Program
ModelOtherBilling cadencePay-as-you-go
Notes

Paragon Healthcare connects eligible patients with financial assistance programs including manufacturer patient assistance programs. Patients are encouraged to contact the home office or visit www.needymeds.org for assistance.

paragonhealthcare.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Paragon Healthcare provides specialty infusion therapy services through an integrated model spanning outpatient infusion centers, home-based infusion delivery with overnight medication shipping, and specialty pharmacy dispensing. The company administers injectable and infusible drug therapies for 300+ chronic and acute conditions including hemophilia, primary immunodeficiency, autoimmune disorders, and other rare diseases. Service lines include Paragon Infusion Centers, Paragon Home Infusion, Paragon Hemophilia, Paragon Specialty Pharmacy, and IVIG therapy, all supported by insurance verification, prior authorization, 24/7 pharmacist support, and coordination with referring physicians.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Paragon serves 35,000+ patients annually and projects to treat 100,000+ patients annually by 2025
Product overview1 text field

Paragon Healthcare operates as a specialty infusion services provider with a portfolio of four integrated core service lines: Paragon Infusion Centers (outpatient clinical settings), Paragon Home Infusion (home-based therapy), Paragon Hemophilia (specialized bleeding disorder division), and Paragon Specialty Pharmacy. These services are unified by shared clinical capabilities in injectable and infusible drug therapies, 24/7 pharmacist availability, overnight medication shipping, insurance verification support, and coordination with referring physicians. The company treats over 300 conditions including rare diseases, bleeding disorders, immune deficiencies, and chronic inflammatory conditions across dermatology, gastroenterology, rheumatology, neurology, and other specialties. All divisions operate under dual accreditation from URAC and ACHC.

Product and service5 records
1Paragon Infusion Centers
CategoryInfusion Therapy Services
Description

Outpatient infusion centers providing injectable and infusible drug therapies in a controlled clinical setting under the care of registered nurses and nurse practitioners, treating 300+ conditions across multiple specialties.

2Paragon Home Infusion
CategoryHome Infusion Services
Description

Home-based infusion therapy allowing patients to receive injectable and infusible medications at home, at work, or on-the-go, with overnight shipping of medications and supplies, home health services arrangement, and telehealth-based self-administration training.

3Paragon Hemophilia
CategorySpecialty Bleeding Disorder Care
Description

Specialized division providing customized care plans, factor replacement therapies, and support services for patients with bleeding disorders including Hemophilia A, Hemophilia B, and von Willebrand Disease.

4Paragon Specialty Pharmacy
CategorySpecialty Pharmacy
Description

Specialty pharmacy providing injectable and infusible medications for conditions across dermatology, gastroenterology, immunology, hepatology, rheumatology, neurology, urology, and other therapeutic specialties.

5IVIG Therapy
CategoryInfusion Therapy Services
Description

Intravenous and subcutaneous immunoglobulin therapy for patients with primary immunodeficiency diseases and autoimmune disorders, available at infusion centers, home infusion, or medical suite settings.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierMinorTypeOthers
Description

Provident Healthcare Partners released a Fall 2024 overview of the infusion services sector, highlighting Paragon Healthcare's sale as a significant transaction in the private equity-backed infusion services market.

Strategic tierMinorTypeOthers
Description

Paragon Healthcare, Inc. supports the National Infusion Center Association (NICA), a 501(c)(3) nonprofit organization focused on improving patient access to intravenous and injectable medications.

Strategic tierMinorTypeOthers
Description

Paragon Healthcare supports the National Multiple Sclerosis Society, which helps people affected by MS by funding cutting-edge research, driving change through advocacy, facilitating professional education, and providing services that help people with MS and their families.

Strategic tierMinorTypeOthers
Description

Hope for Hemophilia is a 501(c)(3) nonprofit helping people living with hemophilia and their families through seasons of crisis since 2009 with financial, emotional, and practical support. Paragon directs patients to this resource.

Strategic tierMinorTypeOthers
Description

Hemophilia Federation of America is a patient education, services and advocacy organization for the rare bleeding disorders community, focused on bleeding disorder patients and caregivers. Paragon directs patients to this resource.

Strategic tierMinorTypeOthers
Description

The Coalition for Hemophilia B strives to make quality of life the focal point of treatment for individuals living with Hemophilia B, pursuing its mission through a family-oriented approach for over 28 years. Paragon directs patients to this resource.

7National Hemophilia Foundation
Strategic tierMinorTypeOthers
Description

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding disorders and preventing complications through education, advocacy, and research. Paragon directs patients to this resource.

paragonhealthcare.com
Strategic tierMinorTypeOthers
Description

Paragon Healthcare connects eligible patients with financial assistance programs through NeedyMeds, a 501(c)(3) nonprofit information resource devoted to helping people in need find assistance programs for their medications and healthcare.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Option Care Health is the largest independent provider of home and alternate-site infusion services in the U.S., operating a national footprint with home infusion, specialty pharmacy, and clinical management across complex therapies. It is the most direct competitor to Paragon's home infusion, specialty pharmacy, and infusion center model.

TypeDirect peer
Description

Pentec Health provides specialty infusion, including intrathecal and parenteral therapies, with a clinical and pharmacy focus on complex patients. It overlaps with Paragon's specialty pharmacy and home infusion capabilities for complex injectable and infusible regimens.

TypeBroad incumbent
Description

Accredo is the specialty pharmacy arm of Evernorth/Express Scripts and a leading distributor of specialty injectable and infusible drugs, including hemophilia and IVIG. It competes with Paragon Specialty Pharmacy for payer contracts and manufacturer limited distribution networks at much larger scale.

TypeDirect peer
Description

Soleo Health is a national specialty infusion provider offering home and alternate-site infusion services, specialty pharmacy, and clinical management for complex conditions. It is a directly comparable mid-market peer to Paragon with overlapping therapeutic areas and referral-based GTM.

TypeDirect peer
Description

BioMatrix is a specialty pharmacy focused on infused and injectable therapies for chronic conditions including hemophilia, IVIG, and rare diseases. It mirrors Paragon's specialty pharmacy + infusion service model and serves many of the same physician specialties and therapeutic categories.

TypeDirect peer
Description

IVX Health operates a national network of outpatient infusion centers focused on biologic infusions for conditions such as rheumatoid arthritis, Crohn's disease, and multiple sclerosis. It directly competes with Paragon Infusion Centers in the outpatient site-of-care category and targets many of the same physician referrals.

TypeDirect peer
Description

Vivo Infusion is an outpatient infusion center operator offering IV therapy for chronic conditions in a clinic setting. It competes with Paragon Infusion Centers for physician referrals and patient volume in overlapping geographies and therapeutic areas.

TypeBroad incumbent
Description

Coram, the infusion services business of CVS Health, provides home infusion and tube feeding nationally as part of CVS's broader pharmacy and care delivery portfolio. It competes head-to-head with Paragon's home infusion offering but benefits from CVS's payer and retail pharmacy scale.

TypeBroad incumbent
Description

Walgreens Specialty Pharmacy, including its specialty infusion and limited distribution drug network, is a broad incumbent competitor in specialty injectable and infusible therapy delivery. It competes with Paragon for payer contracts, manufacturer partnerships, and patient referrals across multiple therapeutic areas.

TypeDirect peer
Description

Amerita is a specialty infusion provider offering home and alternate-site infusion, including IVIG, TPN, and anti-infective therapies. It is a directly comparable peer in home and specialty infusion with a similar referral-driven, accredited business model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries11 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Paragon Healthcare

Specialty Infusion Therapy Servicesparagonhealthcare.com

Paragon Healthcare is a Dallas-based specialty infusion services provider delivering injectable and infusible drug therapies across 40+ U.S. locations through home infusion, outpatient infusion centers, and specialty pharmacy, serving 35,000+ patients annually with chronic and rare conditions including hemophilia and IVIG-therapy indications.

What Paragon Healthcare does

Paragon Healthcare, founded in 2002 and headquartered in Dallas, Texas, is a specialty infusion services provider that delivers injectable and infusible drug therapies through three integrated channels: in-home infusion, a network of company-operated outpatient infusion centers, and specialty pharmacy dispensing. The company treats more than 300 chronic and acute conditions across neurology, rheumatology, gastroenterology, immunology, dermatology, hematology, and hepatology, with particular depth in hemophilia and other bleeding disorders, IVIG/SCIG therapy for primary immunodeficiency and autoimmune disease, and rare disease care. As of 2024, Paragon served over 35,000 patients annually, employed more than 1,000 staff, and operated 40+ infusion center and pharmacy locations across 10+ U.S. states, with a publicly stated plan to add 50+ additional locations over the following five years.

The underlying technology platform combines electronic health information systems, telehealth-enabled patient education for self-administration of infusion pumps and drug therapy, and a national overnight shipping logistics operation that delivers ready-to-use medications and supplies directly to patients. The company operates four core product lines — Paragon Infusion Centers, Paragon Home Infusion, Paragon Hemophilia, and Paragon Specialty Pharmacy — plus an in-office infusion suite offering for physician practices. Paragon holds dual URAC and ACHC accreditations and is HIPAA-compliant, with URAC specialty pharmacy accreditation valid through December 1, 2027. The organization maintains 11 disclosed wholly-owned subsidiaries supporting capabilities such as hemophilia solutions, infusion care, nutrition care, reimbursement, and regional pharmacy operations.

Paragon generates revenue through insurance billing for specialty medications, infusion administration, and care-coordination services (including prior authorizations and benefits verification), supplemented by patient financial assistance programs connected through NeedyMeds and manufacturer programs. Its go-to-market is physician-led referral combined with direct patient outreach, supported by a clinical team of pharmacists, registered nurses, and patient care representatives. Founder-led for two decades, the company received a private-equity investment from Peak Rock Capital in 2020, transitioned to new CEO Anthony Mollica in 2021, and was acquired by Elevance Health in 2024, where it now operates as part of the Carelon health services platform.

Paragon Healthcare firmographics

Firmographics
Name
Paragon Healthcare
Legal name
Paragon Healthcare, Inc.
Website
https://paragonhealthcare.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Paragon Healthcare is a Dallas-based specialty infusion services provider delivering injectable and infusible drug therapies across 40+ U.S. locations through home infusion, outpatient infusion centers, and specialty pharmacy, serving 35,000+ patients annually with chronic and rare conditions including hemophilia and IVIG-therapy indications.
Ownership category
akta.pro rank

Paragon Healthcare industry classification

Industry
Product category
Specialty Infusion Therapy Services
NAICS
All Other Outpatient Care Centers (621498), Other Ambulatory Health Care Services (6219), Ambulatory Health Care Services (621)
SIC
Services-Specialty Outpatient Facilities, Nec (8093), Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)
akta.pro primary industry
Infusion & Home Infusion Pharmacy Services (HLAFALAG)
akta.pro secondary industries
Home Infusion Therapy Providers (HLAFAEAE), Infusion Therapy Centers (Outpatient) (HLAFABAF), Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO), In-Home Infusion Pharmacy Support & Coordination (HSABALAH)

Keywords

  • Specialty infusion therapy
  • Home infusion services
  • Specialty pharmacy dispensing
  • Hemophilia treatment management
  • IVIG therapy services

Where Paragon Healthcare is headquartered

Location

Headquarters

HQ city
Dallas
HQ country
United States
HQ region
North America

Offices49 records

Markets served

Paragon Healthcare business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

  1. Specialty Pharmacy and Infusion Services: Revenue is generated through the provision of specialty injectable and infusible drug therapies, administered either in the patient's home, at one of Paragon's infusion centers, or through specialty pharmacy dispensing. The company handles billing for medications, infusion services, and related care coordination services including prior authorizations and reimbursement management. As of 2018, the company reported approximately $275 million in annual revenue.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goPatient Financial Assistance Program

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Paragon Healthcare product offering

Product offering

Core offering

Paragon Healthcare provides specialty infusion therapy services through an integrated model spanning outpatient infusion centers, home-based infusion delivery with overnight medication shipping, and specialty pharmacy dispensing. The company administers injectable and infusible drug therapies for 300+ chronic and acute conditions including hemophilia, primary immunodeficiency, autoimmune disorders, and other rare diseases. Service lines include Paragon Infusion Centers, Paragon Home Infusion, Paragon Hemophilia, Paragon Specialty Pharmacy, and IVIG therapy, all supported by insurance verification, prior authorization, 24/7 pharmacist support, and coordination with referring physicians.

Product overview

Paragon Healthcare operates as a specialty infusion services provider with a portfolio of four integrated core service lines: Paragon Infusion Centers (outpatient clinical settings), Paragon Home Infusion (home-based therapy), Paragon Hemophilia (specialized bleeding disorder division), and Paragon Specialty Pharmacy. These services are unified by shared clinical capabilities in injectable and infusible drug therapies, 24/7 pharmacist availability, overnight medication shipping, insurance verification support, and coordination with referring physicians. The company treats over 300 conditions including rare diseases, bleeding disorders, immune deficiencies, and chronic inflammatory conditions across dermatology, gastroenterology, rheumatology, neurology, and other specialties. All divisions operate under dual accreditation from URAC and ACHC.

Differentiator

Problem solved

Functional benefit

Products and services

  • Paragon Infusion Centers Outpatient infusion centers providing injectable and infusible drug therapies in a controlled clinical setting under the care of registered nurses and nurse practitioners, treating 300+ conditions across multiple specialties.
  • Paragon Home Infusion Home-based infusion therapy allowing patients to receive injectable and infusible medications at home, at work, or on-the-go, with overnight shipping of medications and supplies, home health services arrangement, and telehealth-based self-administration training.
  • Paragon Hemophilia Specialized division providing customized care plans, factor replacement therapies, and support services for patients with bleeding disorders including Hemophilia A, Hemophilia B, and von Willebrand Disease.
  • Paragon Specialty Pharmacy Specialty pharmacy providing injectable and infusible medications for conditions across dermatology, gastroenterology, immunology, hepatology, rheumatology, neurology, urology, and other therapeutic specialties.
  • IVIG Therapy Intravenous and subcutaneous immunoglobulin therapy for patients with primary immunodeficiency diseases and autoimmune disorders, available at infusion centers, home infusion, or medical suite settings.

Quantifiable outcome

  • Paragon serves 35,000+ patients annually and projects to treat 100,000+ patients annually by 2025

Companies that use Paragon Healthcare

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Paragon Healthcare technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Paragon Healthcare partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered minor.

  • Provident Healthcare PartnersminorOthersProvident Healthcare Partners released a Fall 2024 overview of the infusion services sector, highlighting Paragon Healthcare's sale as a significant transaction in the private equity-backed infusion services market.
  • National Infusion Center Association (NICA)minorOthersParagon Healthcare, Inc. supports the National Infusion Center Association (NICA), a 501(c)(3) nonprofit organization focused on improving patient access to intravenous and injectable medications.
  • National Multiple Sclerosis SocietyminorOthersParagon Healthcare supports the National Multiple Sclerosis Society, which helps people affected by MS by funding cutting-edge research, driving change through advocacy, facilitating professional education, and providing services that help people with MS and their families.
  • Hope for HemophiliaminorOthersHope for Hemophilia is a 501(c)(3) nonprofit helping people living with hemophilia and their families through seasons of crisis since 2009 with financial, emotional, and practical support. Paragon directs patients to this resource.
  • Hemophilia Federation of AmericaminorOthersHemophilia Federation of America is a patient education, services and advocacy organization for the rare bleeding disorders community, focused on bleeding disorder patients and caregivers. Paragon directs patients to this resource.
  • The Coalition for Hemophilia BminorOthersThe Coalition for Hemophilia B strives to make quality of life the focal point of treatment for individuals living with Hemophilia B, pursuing its mission through a family-oriented approach for over 28 years. Paragon directs patients to this resource.
  • National Hemophilia FoundationminorOthersThe National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding disorders and preventing complications through education, advocacy, and research. Paragon directs patients to this resource.
  • NeedyMedsminorOthersParagon Healthcare connects eligible patients with financial assistance programs through NeedyMeds, a 501(c)(3) nonprofit information resource devoted to helping people in need find assistance programs for their medications and healthcare.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Paragon Healthcare competitors and assessment

Company assessment

Direct peers

  • Option Care Health: Option Care Health is the largest independent provider of home and alternate-site infusion services in the U.S., operating a national footprint with home infusion, specialty pharmacy, and clinical management across complex therapies. It is the most direct competitor to Paragon's home infusion, specialty pharmacy, and infusion center model.
  • Pentec Health: Pentec Health provides specialty infusion, including intrathecal and parenteral therapies, with a clinical and pharmacy focus on complex patients. It overlaps with Paragon's specialty pharmacy and home infusion capabilities for complex injectable and infusible regimens.
  • Soleo Health: Soleo Health is a national specialty infusion provider offering home and alternate-site infusion services, specialty pharmacy, and clinical management for complex conditions. It is a directly comparable mid-market peer to Paragon with overlapping therapeutic areas and referral-based GTM.
  • BioMatrix Specialty Pharmacy: BioMatrix is a specialty pharmacy focused on infused and injectable therapies for chronic conditions including hemophilia, IVIG, and rare diseases. It mirrors Paragon's specialty pharmacy + infusion service model and serves many of the same physician specialties and therapeutic categories.
  • IVX Health: IVX Health operates a national network of outpatient infusion centers focused on biologic infusions for conditions such as rheumatoid arthritis, Crohn's disease, and multiple sclerosis. It directly competes with Paragon Infusion Centers in the outpatient site-of-care category and targets many of the same physician referrals.
  • Vivo Infusion: Vivo Infusion is an outpatient infusion center operator offering IV therapy for chronic conditions in a clinic setting. It competes with Paragon Infusion Centers for physician referrals and patient volume in overlapping geographies and therapeutic areas.
  • Amerita: Amerita is a specialty infusion provider offering home and alternate-site infusion, including IVIG, TPN, and anti-infective therapies. It is a directly comparable peer in home and specialty infusion with a similar referral-driven, accredited business model.

Broad incumbents

  • Accredo (Express Scripts / Evernorth): Accredo is the specialty pharmacy arm of Evernorth/Express Scripts and a leading distributor of specialty injectable and infusible drugs, including hemophilia and IVIG. It competes with Paragon Specialty Pharmacy for payer contracts and manufacturer limited distribution networks at much larger scale.
  • Coram CVS Health (Coram): Coram, the infusion services business of CVS Health, provides home infusion and tube feeding nationally as part of CVS's broader pharmacy and care delivery portfolio. It competes head-to-head with Paragon's home infusion offering but benefits from CVS's payer and retail pharmacy scale.
  • Walgreens Specialty Pharmacy (including Option Care legacy): Walgreens Specialty Pharmacy, including its specialty infusion and limited distribution drug network, is a broad incumbent competitor in specialty injectable and infusible therapy delivery. It competes with Paragon for payer contracts, manufacturer partnerships, and patient referrals across multiple therapeutic areas.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Paragon Healthcare social profiles

Digital presence

Paragon Healthcare compliance and trust

Trust signal

Compliance3 records

Paragon Healthcare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Paragon Healthcare leadership team

Management profile

Number of profiles

Profiles4 records

Paragon Healthcare subsidiaries and ownership

Company hierarchy

Subsidiaries11 records

Paragon Healthcare funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Paragon Healthcare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Paragon Healthcare

What does Paragon Healthcare do?

Paragon Healthcare provides specialty infusion therapy services through an integrated model spanning outpatient infusion centers, home-based infusion delivery with overnight medication shipping, and specialty pharmacy dispensing. The company administers injectable and infusible drug therapies for 300+ chronic and acute conditions including hemophilia, primary immunodeficiency, autoimmune disorders, and other rare diseases. Service lines include Paragon Infusion Centers, Paragon Home Infusion, Paragon Hemophilia, Paragon Specialty Pharmacy, and IVIG therapy, all supported by insurance verification, prior authorization, 24/7 pharmacist support, and coordination with referring physicians.

Is Paragon Healthcare a public or private company?

Paragon Healthcare is a private company. It is classified as corporate owned and is currently operating.

When was Paragon Healthcare founded?

Paragon Healthcare was founded in 2002. It employs 1,001 to 5,000 people.

Where is Paragon Healthcare based?

Paragon Healthcare is headquartered in Dallas, United States, in the North America region.

How does Paragon Healthcare make money?

One revenue line is on record: specialty Pharmacy and Infusion Services.

Who are Paragon Healthcare's main competitors?

Direct peers on record are Option Care Health, Pentec Health, Soleo Health, BioMatrix Specialty Pharmacy, IVX Health, Vivo Infusion and Amerita. Broad incumbents are Accredo (Express Scripts / Evernorth), Coram CVS Health (Coram) and Walgreens Specialty Pharmacy (including Option Care legacy).

Does Paragon Healthcare have an API?

No public API is recorded for Paragon Healthcare.

What industry is Paragon Healthcare in?

Paragon Healthcare's product category is Specialty Infusion Therapy Services. Its primary akta.pro industry code is HLAFALAG, Infusion & Home Infusion Pharmacy Services, with a secondary code of HLAFAEAE, Home Infusion Therapy Providers. Its NAICS code is 621498 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ParagoninstituteRe: Request for Information: Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical CareThe Paragon Health Institute submitted comments to the U.S. Department of Health and Human Services (HHS) advocating for increased AI deployment in American healthcare to reduce costs and improve quality. The submission highlights the potential of AI to address healthcare spending, reimbursement challenges, regulatory evolution, and the autonomy of AI-enabled medical devices. It emphasizes collaboration and structural reforms needed to accelerate AI adoption and innovation in clinical care.ProvidenthpPrivate Equity Investment in Infusion ServicesProvident Healthcare Partners released a Fall 2024 overview of the infusion services sector, highlighting two significant private equity-backed exits this year: Peak Rock Capital's sale of Paragon Healthcare to Elevance Health and Boyne Capital's sale of Infusion Associates to Vivo Infusion (backed by InTandem Capital). The report estimates the current infusion services market at $120 billion, with hospital settings accounting for 55% of care distribution, followed by physician office infusion centers (30%), home (10%), and ambulatory infusion centers (5%).Elevance HealthElevance Health Announces Closing of Paragon Healthcare AcquisitionElevance Health announced the closing of its acquisition of Paragon Healthcare, a provider of infusion and specialty pharmacy services. The acquired company will operate as part of Elevance's CarelonRx segment, expanding Elevance's capabilities in delivering affordable access to specialty medications for chronic conditions. This move is intended to deepen Elevance's service footprint across eight states and improve patient adherence and cost efficiency.Business Wire BlogElevance Health Announces Closing of Paragon Healthcare AcquisitionElevance Health announced the closing of its acquisition of Paragon Healthcare, a provider of infusion and specialty pharmacy services. The acquisition integrates Paragon into Elevance's CarelonRx segment to expand capabilities in multi-site infusion services and enhance access for patients with chronic illnesses.PR NewswirePEAK ROCK CAPITAL AFFILIATE SELLS PARAGON HEALTHCARE, INC. TO ELEVANCE HEALTHAn affiliate of private investment firm Peak Rock Capital has signed a definitive agreement to sell Paragon Healthcare, Inc. to Elevance Health. During Peak Rock's ownership, Paragon more than doubled its revenue and expanded its infusion center footprint by 400%. The transaction includes financial advice from Jefferies LLC and legal counsel from Kirkland & Ellis LLP.FinSMEsElevance Health Acquires Paragon HealtcareElevance Health has acquired Paragon Healthcare, a Texas-based provider of infusion and specialty pharmacy services, to enhance its capabilities in managing chronic and complex illnesses. The financial terms of the deal were not disclosed, but the acquisition aims to improve access to specialized medications for Elevance's members. This move expands Elevance's network of ambulatory infusion centers and home infusion pharmacies across multiple U.S. states.AccessmarketintellElevance Health Agrees to Acquire Paragon HealthcareElevance Health has entered into an agreement to acquire Paragon Healthcare, a provider of infusion and specialty pharmacy services. Following the acquisition, Paragon will operate as part of CarelonRx, Elevance's pharmacy services segment, allowing for the integration of medical and pharmacy data to enhance patient care. This transaction follows Paragon's previous acquisition by Peak Rock Capital in 2020.BioSpaceElevance Health to Acquire Paragon HealthcareElevance Health announced an agreement to acquire Paragon Healthcare, a specialty pharmacy provider specializing in infusion services. The transaction is expected to close in the first half of 2024 and will integrate Paragon into Elevance's CarelonRx segment to expand its multi-site infusion capabilities. The acquisition is not expected to have a material impact on adjusted earnings per share for 2024.Elevance HealthElevance Health to Acquire Paragon HealthcareElevance Health announced an agreement to acquire Paragon Healthcare, a specialty infusion services provider, in a transaction expected to close in the first half of 2024. The acquisition aims to deepen Elevance's capabilities in providing affordable access to specialty medications and expand Paragon's geographical footprint across its eight-state network.PR NewswirePeak Rock Capital Affiliate Completes Acquisition of Paragon Healthcare, Inc.An affiliate of Peak Rock Capital has completed its acquisition of Paragon Healthcare, Inc., a leading provider of ambulatory and home infusion services and specialty pharmacy services. The transaction, conducted in partnership with Paragon's existing management team, represents Peak Rock's expansion into the healthcare sector with companies showing significant growth potential. Paragon, founded in 2002 and headquartered in Dallas, Texas, operates pharmacy and infusion locations across nine U.S. states.